Moneta Group Investment Advisors LLC Adc Therapeutics Sa Transaction History

Moneta Group Investment Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 16, 2023	SELL	$2.87 - $5.24 $6,994 - $12,769	-2,437 Reduced 11.11%	19,496 $74,000
Q4 2022 Feb 16, 2023	SELL	$2.87 - $5.24 $62.9 Million - $115 Million	-21,911,140 Reduced 99.9%	21,933 $84,000
Q4 2022 Feb 15, 2023	BUY	$2.87 - $5.24 $62.9 Million - $115 Million	21,913,571 Added 112365.76%	21,933,073 $84.2 Million
Q3 2022 Nov 14, 2022	BUY	$4.66 - $10.31 $23 - $51	5 Added 0.03%	19,502 $94,000
Q2 2022 Aug 15, 2022	BUY	$5.96 - $14.99 $166 - $419	28 Added 0.14%	19,497 $155,000
Q1 2022 May 11, 2022	SELL	$13.28 - $20.03 $478 - $721	-36 Reduced 0.18%	19,469 $286,000
Q4 2021 Feb 11, 2022	SELL	$19.29 - $31.51 $173 - $283	-9 Reduced 0.05%	19,505 $394,000
Q3 2021 Nov 12, 2021	BUY	$20.45 - $30.0 $143 - $210	7 Added 0.04%	19,514 $530,000
Q2 2021 Aug 13, 2021	BUY	$20.38 - $27.04 $142 - $189	7 Added 0.04%	19,507 $475,000
Q1 2021 May 14, 2021	BUY	$22.75 - $34.05 $443,625 - $663,975	19,500 New	19,500 $476,000

52.9M

300K

59.3K

Ticker ADCT
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,645,296
Market Cap $236M
Description
ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...

Get notified when there are updates to the investment portfolio of Moneta Group Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Moneta Group Investment Advisors LLC with notifications on news.